Epstein-Barr virus (EBV) DNA structure and gene expression were analyzed in tissue specimens from oral hairy leukoplakia (HLP), a mucocutaneous lesion that develops in patients infected with human immunodeficiency virus (HIV). The structure of the terminal restriction enzyme fragments of EBV revealed that HLP is a permissive infection without a predominant, detectable population of EBV episomal DNA. In RNA preparations from this uniquely permissive infection, EBV replicative mRNAs could be identified by Northern analysis; however, the virally encoded small nuclear RNAs, the EBERs, were not detected in most HLP RNA preparations. In situ hybridization detected EBER expression in very rare cells. These data indicate that unlike other viral small nuclear RNAs, the EBERs are not expressed during viral replication and must participate in the complex maintenance of latent EBV infection.Oral hairy leukoplakia (HLP) is a newly recognized lesion, most often located on the tongue, that occurs almost exclusively in patients with human immunodeficiency virus (HIV) infection (1). Epstein-Barr virus (EBV), usually thought of as a lymphotrophic herpesvirus, is the etiologic agent of this mucocutaneous epithelial cell disorder. HLP is the only EBV-associated disease in which acyclovir, an antiviral drug that inhibits the replication of EBV, induces clinical remission (2). This response and the detection of masses of viral particles in the infected cells make these lesions unique in EBV biology and indicate that the virus is actively replicating (1,2).Replication is relatively unusual in EBV-infected cells. Although the virus replicates in oropharyngeal epithelial cells, the transforming infection of B lymphocytes, which is the hallmark of EBV infection, is largely nonpermissive (3-6). In the latently infected B-cell lines, the viral DNA is maintained as an episome (7,8). Permissive infection develops in a small subset of cells with the expression of multiple replicative RNAs and the generation of the linear, virion form of DNA. The structure of the EBV termini permits discrimination between the linear and episomal DNA forms and therefore between permissive and latent states (9, 10).In EBV-infected cells, the most abundantly expressed viral transcripts are the nonpolyadenylylated polymerase III transcripts, EBER1 and EBER2 (EBV-encoded small nuclear RNA), which are found in ribonucleoprotein particles (RNP) (11,12). Despite their abundance, the function ofthese RNAs is unknown. The EBERs can partially substitute for the similarly sized polymerase III virus-associated (VA) transcripts encoded by adenovirus that function during viral replication (13,14). This complementation suggested that perhaps, like the VA RNAs, the EBERs also function during lytic replication. This observation was supported by studies that revealed that the EBERs are more abundant in the partially permissive virus-producer cell line B95-8 than in a latently infected lymphoid line, IB4, established by infection with B95-8 virus (15, 16). However, in co...

No abstract

Influenza infection results in substantial morbidity and mortality in hospitalized patients, including those who are immunocompromised or pregnant. Antiviral therapy likely provides considerable benefit to these patients, but few studies have been successfully conducted in these high-risk populations, and no drugs are specifically licensed for treating these subgroups. One of the key challenges facing novel antiviral drug development for influenza is determining the appropriate efficacy end points that would enable rapid regulatory approval for drug use in seriously ill patients, for whom risk-benefit assessments differ from those with uncomplicated illness. All available antiviral drugs currently affect viral replication, and respiratory tract viral titers correlate with both symptoms and measures of host inflammatory responses, including cytokine and chemokine expression that are likely responsible for many of the clinical symptoms. Consequently, we outline the evidence to support the use of primary virological end points in studies of antiviral agents involving patients who are hospitalized with severe influenza or those who are at high risk of severe and life-threatening disease.

Transcription of Epstein-Barr virus (EBV) genes in epithelial tissue, one of the two principal cell types infected by EBV, is not well characterized. EBV transcription in a nasopharyngeal carcinoma established in nude mice, C15, has been analyzed by using strand-specific RNA probes and sequence analysis of a C15 cDNA library. In C15, two equally abundant mRNAs of 3.7 and 2.8 kilobases (kb) are encoded by the sequences that encode latent membrane protein (LMP). Hybridization with probes specific for the 3' end of the LMP mRNA to Northern (RNA) blots and sequence analysis of cDNAs representing the messages indicated that the 3.7and 2.8-kb mRNAs are 3' coterminal. Sequence analysis of additional cDNAs revealed an mRNA that is spliced identically to the LMP mRNA but is initiated 5' to the promoter for LMP. A probe representing the sequences contained within the cDNA which are 5' to the LMP promoter identffied the 3.7-kb mRNA in C15 and a low-abundance 3.7-kb mRNA in B95-8 RNA. These data indicate that transcription of the LMP-encoding sequences is complex and that LMP can be expressed from an additional RNA in both nasopharyngeal carcinoma and lymphoid cells. Hybridization with BamHI-A identified a predominant 4.8-kb mRNA and two less abundant larger-molecular-weight mRNAs transcribed in C15. These mRNAs are consistently expressed in all passages in nude mice of the C15 tumor. Hybridization with strand-specific probes and sequence analysis of three cDNAs revealed that these mRNAs are transcribed from left to right. Sequence analysis of cDNAs representing the 3' end of the mRNAs identified an open reading frame that could potentially encode a protein 4948 on July 6, 2020 by guest

Purification steps for isolating therapeutic proteins from human plasma showed the removal of both PrP(Sc) and TSE infectivity. PrP(Sc) partitioning coincided with infectivity partitioning, which showed a close relationship between PrP(Sc) and TSE infectivity. By exploiting this association, the in vitro Western blot assay for PrP(Sc) was valuable for estimating the partitioning of TSE infectivity during plasma protein purification.